文献速递复苏、休克与脓毒症中毒与环境急症

非处方药物相关院外心脏骤停:发病率随时间的变化及接受复苏的比值比

Non-prescription drug-associated out-of-hospital cardiac arrest: Changes in incidence over time and the odds of receiving resuscitation.
PubMed 文献 · Resuscitation · 2023-12-30
一句话结论2016-2022年非处方药物相关院外心脏骤停经EMS治疗发病率从3.7升至9.1/10万人年,且接受EMS治疗的比值比更高(AOR 1.34)。

该研究利用大型省级心脏骤停登记数据库,纳入2016-2022年连续、非创伤性成人院外心脏骤停(OHCA)病例,将24小时内有非处方药物使用史或现场有吸毒器具证据者归类为药物相关OHCA(DA-OHCA)。在33,365例EMS评估病例中,EMS治疗的OHCA有1,985/18,591(11%)为DA-OHCA,EMS未治疗的OHCA有887/9,200(9.6%)为DA-OHCA。EMS治疗的DA-OHCA发病率从2016年3.7/10万人年升至2022年9.1/10万人年,占全部OHCA比例从6.1%升至11.5%。DA-OHCA与更高的EMS治疗比值比相关(AOR 1.34;95%CI 1.13-1.58)。

要点

  • 2016-2022年EMS治疗的DA-OHCA发病率从3.7升至9.1/10万人年,占全部OHCA比例从6.1%升至11.5%。
  • EMS治疗的DA-OHCA中位年龄40岁(IQR 31-51),53%(1,059例)有已知非处方药物使用史,29%(570例)发生在公共场所。
  • DA-OHCA与接受EMS治疗的比值比升高相关(AOR 1.34;95%CI 1.13-1.58)。
  • EMS治疗的OHCA总发病率从60升至79/10万人年,DA-OHCA仅占其中少数。
  • EMS治疗的OHCA中11%(1,985/18,591)为DA-OHCA,EMS未治疗的OHCA中9.6%(887/9,200)为DA-OHCA。

适用人群与场景

  • 2016-2022年大型省级心脏骤停登记数据库中连续、非创伤性成人OHCA病例,由EMS评估。

诊断标准与关键阈值

  • DA-OHCA分类标准:有前24小时内非处方药物使用史,或现场有吸毒器具证据。

研究设计与关键结果

  • 研究类型为基于大型省级心脏骤停登记数据库的队列分析,纳入2016-2022年连续、非创伤性成人OHCA共33,365例EMS评估病例。
  • EMS治疗的OHCA中DA-OHCA为1,985/18,591(11%),EMS未治疗的OHCA中DA-OHCA为887/9,200(9.6%)。
  • EMS治疗的DA-OHCA中位年龄40岁(IQR 31-51),1,059例(53%)有已知非处方药物使用史,570例(29%)发生在公共场所。
  • 2016至2022年,EMS治疗的OHCA发病率从60升至79/10万人年;EMS治疗的DA-OHCA发病率从3.7升至9.1/10万人年。
  • 全部OHCA中被归类为DA-OHCA的比例从6.1%升至11.5%。
  • DA-OHCA与更高的EMS治疗比值比相关(AOR 1.34;95%CI 1.13-1.58)。

证据类型、等级与局限

  • 证据类型:基于大型省级心脏骤停登记数据库的队列分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐;研究结论为DA-OHCA发病率近三倍升高,但仅占研究期间全部OHCA增加的一小部分,且DA-OHCA与接受EMS治疗的比值比升高相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Multiple jurisdictions reported a significant increase in out-of-hospital cardiac arrest (OHCA) incidence over the past decade, however the reasons for this remain unclear. We investigated how drug-associated OHCA (DA-OHCA) contributed to overall OHCA incidence, and whether the likelihood of treatment by emergency medical services (EMS) was associated with DA-OHCA classification.

METHODS: Using a large provincial cardiac arrest registry, we included consecutive, non-traumatic adult OHCA from 2016-2022. We classified as drug-associated if there were historical accounts of non-prescription drug use within the preceding 24 hours or evidence of paraphernalia at the scene. We examined year-by-year trends in OHCA and DA-OHCA incidence. We also investigated the association between DA-OHCA and odds of EMS treatment using an adjusted logistic regression model.

RESULTS: Of 33,365 EMS-assessed cases, 1,985/18,591 (11%) of EMS-treated OHCA and 887/9,200 (9.6%) of EMS-untreated OHCA were DA-OHCA. Of EMS-treated DA-OHCA, the median age was 40 years (IQR 31-51), 1,059 (53%) had a known history of non-prescription drug use, and 570 (29%) were public-location. From 2016 to 2022, EMS-treated OHCA incidence increased from 60 to 79 per 100,000 person-years; EMS-treated DA-OHCA incidence increased from 3.7 to 9.1 per 100,000 person-years. The proportion of overall OHCA classified as DA-OHCA increased from 6.1% to 11.5%. DA-OHCA was associated with greater odds of EMS treatment (AOR 1.34; 95%CI 1.13-1.58).

CONCLUSION: Although EMS-treated DA-OHCA incidence increased by nearly three-fold, it comprised a minority of the overall OHCA increase during the study period. DA-OHCA was associated with an increased likelihood of EMS treatment.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Mok V, Brebner C, Yap J, et al. Non-prescription drug-associated out-of-hospital cardiac arrest: Changes in incidence over time and the odds of receiving resuscitation. Resuscitation. 2023. PMID: 38160902. doi:10.1016/j.resuscitation.2023.110107

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。